Retension Pharmaceuticals
RTSN12.2700.16% ( +0.020 )
Overview
Retension Pharmaceuticals (RTSN)
Retension Pharmaceuticals, Inc. operates as a clinical -stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and ot...
- Open
- 12.300
- High
- 12.700
- Low
- 11.370
- Prev. Close
- 12.250
- Volume
- 124.99K
- Turnover
- 1.51M
- Avg Price
- 12.110
- Bid/Ask Ratio
- --
- Amplitude
- 10.86%
- 52wk High
- 18.640
- Volume Ratio
- 0.00
- Turnover Ratio
- 2.26%
- 52wk Low
- 9.660
- Float Mkt Cap
- 67.85M
- Market CapUSD
- 102.23M
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -1.71
- EPSDynamic
- -1.81
- EPSStatic
- --
- BVPS
- -1.79
- P/B
- --
- Circulating Supply
- 5.53M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 8.33M
- Min lot size
- 1
- Currency
- USD
Retension Pharmaceuticals Analyst Rating
View moreForecast & Rating
Nov 9, 2026Price forecast
$51.67321.08%
Forecast & RatingStrong buy
3analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Market Movers ·
Retension Pharmaceuticals falls 10% during regular trading
- Market Movers ·
Retension Pharmaceuticals surges 16% during regular trading
- Market Movers ·
Retension Pharmaceuticals tumbles 8% during regular trading
- PUBT ·
Retension Pharmaceuticals to Participate in Fireside Chat at Guggenheim Healthcare Innovation Conference
- Market Movers ·
Retension Pharmaceuticals climbs 9% during regular trading
- Market Movers ·
Retension Pharmaceuticals surges 8% during regular trading
